pimozide has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyle, JA; Curtis, DJ; Evans, K; Haigh, JJ; Haigh, K; Jane, SM; Litalien, V; Lock, RB; McCalmont, H; Saw, J; Tremblay, CS | 1 |
1 other study(ies) available for pimozide and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
STAT5 activation promotes progression and chemotherapy resistance in early T-cell precursor acute lymphoblastic leukemia.
Topics: Animals; Humans; Interleukin-7; Mice; Mice, Transgenic; Pimozide; Precursor Cells, T-Lymphoid; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; STAT5 Transcription Factor | 2023 |